Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice

Leukemia

Volumn 10, Issue 9, 1996, Pages 1471-1478

  Steenbergen, E J ^a   Verhagen, O J H M ^a   Nibbering, C P ^a   Van Den Berg, H ^b   Van Leeuwen, E F ^b   Behrendt, H ^b   Von Dem Borne, A E G Kr ^a,c   Van Der Schoot, C E ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

B precursor ALL; Clonal evolution; SCID

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LEUKEMIA; CELL CYCLE S PHASE; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOPHENOTYPING; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RELAPSE;

EID: 0029740084     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alt FW, Oltz EM, Young F, Gorman J, Taccioli C, Chen J. VDJ recombination, Immunol Today 1992; 13: 306-314.
2. Van Dongen JJM, Wolvers-Tettero ILM. Analysis of immunoglobulin and T cell receptor genes. Clinica Chimica acta 1991; 198: 1-174.
3. Nizet Y, Martiat P, Vaerman JL, Philippe M, Wildmann C, Staelens JP, Cornu G, Ferrant A, Michaux JL, Sokal G. Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. Br J Haematol 1991; 79: 205-210.
4. Nizet Y, van Daele S, Lewalle P, Vaerman JL, Philippe M, Vermylen C, Cornu G, Ferrant A, Michaex JL, Martiat P. Long term follow-up of residual disease in acute lymphoblaslic leukemia patients in complete remission using clonogenic IgH probes and the polymerase chain reaction. Blood 1993; 82: 1618-1625.
5. Cave H, Guidal C, Rohrlich P, Delfau MH, Broyard A, Lescoeur B, Rahimy C, Fenneteau O, Monplaisir N, D'Auriol L, Elion J, Vilmer E, Grandchamp B. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of δ and gamma T-cell receptor genes. Blood 1994; 83: 1892-1902.
6. Brisco MJ, Condon J, Hughes E, Neoh S, Sykes PJ, Seshadri R, Toogood I, Waters K, Tauro G, Ekert H, Morley AA. Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet 1994; 343: 196-199.
7. Beishuizen A, Verhoeven MAJ, Hählen K, Van Wering ER, Van Dongen JJM. Differences in immunoglobulin heavy chain rearrangement patterns between bone marrow and blood samples in childhood B-acute lymphoblastic leukemia at diagnosis. Leukemia 1992; 6: 60-63.
8. Steward CC, Goulden NJ, Katz F, Baines D, Martin PC, Langlands K, Potter MN, Chessells JM, Oakhill A. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor 5 gene rearrangements between presentation and relapse of childhood B-Iineage acute lymphoblastic leukemia. Blood 1994; 83: 1355-1362.
9. Bird J, Galili N, Link M, Stites D, Sklar J. Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med 1988; 168: 229-245.
10. Wasserman R, Yamada M, Ito Y, Finger LR, Reichard BA, Shane S, Lange B, Rovera G. VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 223-228.
11. Kitchingman GR. Immunoglobulin heavy chain gene VH-D junctional diversity at diagnosis in patients with acute lymphoblastic leukemia. Blood 1993; 81: 775-782.
12. Steenbergen EJ, Verhagen OJHM, van Leeuwen EF, von dem Borne AEGKr, van der School CE. Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia. Blood 1993; 82: 581-589.
13. Bories JC, Cayuela JM, Loiseau P, Sigaux F. Expression of human recombination activating genes (RAG1 and RAG2) in neoplastic lymphoid cells: correlation with cell differentiation and antigen receptor expression. Blood 1991; 78: 2053-2061.
14. Umiel T, Pattengale P, Weinberg K. Recombination activating gene (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia. Leukemia 1992; 7: 435-440.
15. Yoneda N, Tatsumi E, Kawano S, Matsuo Y, Minowada J, Yamaguchi N. Human recombination activating gene-1 expression in leukemia/lymphoma cells: expression depends on stage of lymphoid differentiation defined by phenotype and genotype. Blood 1993; 82: 207-216.
16. Reid SK, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE. A model of human acute lymphoblastic leukemia in immune deficient SCID mice. Science 1989; 246: 1597-1600.
17. Cesano A, O'Connor R, Lange B, Finan J, Rovera G, Santoli D. Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice. Blood 1991; 77: 2463-2474.
18. De Lord C, Clutterbuck R, Titley J, Ormerod M, Gordon-Smith T, Millar J, Powles R. Growth of primary human acute leukemia in severe combined immunodeficient mice. Exp Hematol 1995; 19: 991-993.
19. Kamel-Reid S, Letarte M, Doedens M, Greaves A, Murdoch B, Grunberger T, Lapidot T, Thorner P, Freedman MH, Phillips RA, Dick JE. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and dissiminates rapidly in SCID mice. Blood 1991; 78: 2973-2981.
20. Uckun FM, Downing JR, Chelstrom LM, Gunther R, Ryan M, Simon J, Carroll AJ, Tuel-Ahlgren L, Crist WM. Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 1994; 84: 859-865.
21. Uckun FM, Sather H, Reaman C, Shuster J, Land V, Trigg M, Gunther R, Chelstrom L, Bleyer A, Gaynon P, Crist W. Leukmic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia. Blood 1995; 85: 873-878.
22. Jeffreys AJ, Flavell RA. A physical map of the DNA regions flanking the rabbit β-globin gene. Cell 1977; 12: 429-439.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: New York, 1989.
24. Takahashi N, Nakai N, Honjo T. Cloning of human immunoglobulin μ gene and comparison with mouse μ gene. Nucleic Acids Res 1980; 8: 5983-5991.
25. Groffen J, Stephenson JR, Heisterkamp N, De Klein A, Bartram CR, Grosveld G. Philadelphia chromosome breakpoints are clustered within a limited region, BCR, on chromosome 22. Cell 1984; 36: 93-95.
26. Küppers R, Zhao M, Hansmann M-L, Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993; 12: 4955-4967.
27. Ichihara Y, Matsuoka H, Kurosawa Y. Organization of human immunoglobulin heavy chain diversity gene loci. EMBO J 1988; 7: 4141-4150.
28. Matsuda F, Shin EK, Hirabayashi Y, Nagaoka H, Yoshida MC, Zong SQ, Honjo T. Organization of variable region segments of the human immunoglobulin heavy chain: duplication of the D5 cluster within the locus and interchromosomal translocation of variable region segments. EMBO J 1990; 9: 2501-2506.
29. Buluwela L, Albertson DG, Sherrington P, Rabbitts PH, Spurr N, Rabbitts TH. The use of chromosomal translocations to study human immunoglobulin gene organization: mapping DH segments within 35 kb of the Cμ gene and identification of a new DH locus. EMBO J 1988; 7: 2003-2010.
30. Sonntag D, Weingartner B, Grutzmann R. A member of a novel human DH gene family: DHFL16. Nucleic Acids Res 1989; 17: 1267.
31. Ravetch JV, Siebenlist U, Korsmeyer S, Waldmann T, Leder T. Structure of the human immunoglobulin μ locus: characterization of embryonic and rearranged J and D genes. Cell 1981; 27: 583-691.
32. Steenbergen EJ, Verhagen OJHM, van Leeuwen EF, Behrendt H, Merle PA, von dem Borne AEGKr, van der Schoot CE. B precursor acute lymphoblastic leukemia third complementarity determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life. Fur J Immunol 1994; 24: 900-908.
33. Steenbergen EJ, Verhagen OJHM, van Leeuwen EF, van den Berg H, Behrendt H, von dem Borne AEGKr, van der Schoot CE. IgH/TCRδ PCR-oligonucleotide liquid hybridization, a fast and sensitive technique for monitoring minimal residual disease in childhood B-precursor acute lymphoblastic leukemia. Leukemia 1995; 9: 216-222.
34. Kaspers GJL, Smets LA, Pieters R, Van Zantwijk CH, Van Wering ER, Veerman AJP. Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: result of an in vitro study. Blood 1995; 85: 751-756.
35. Lafaille JJ, DeCloux A, Bonneville M, Takagaki Y, Tonegawa S. Junctional sequences of T cell receptor gamma delta genes: implications for gamma delta T cell lineages and for a novel intermediate of V-(D)-J joining. Cell 1989; 59: 859-870.